Deciphering the relationship between SARS-CoV-2 and cancer
M Costanzo, MAR De Giglio, GN Roviello - International Journal of …, 2023 - mdpi.com
Some viruses are known to be associated with the onset of specific cancers. These
microorganisms, oncogenic viruses or oncoviruses, can convert normal cells into cancer …
microorganisms, oncogenic viruses or oncoviruses, can convert normal cells into cancer …
Tryptophan‐Kynurenine Pathway in COVID‐19‐Dependent Musculoskeletal Pathology: A Minireview
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), affecting multiple organ systems, including the respiratory tract …
disease 2019 (COVID‐19), affecting multiple organ systems, including the respiratory tract …
Human-derived air–liquid interface cultures decipher Alzheimer's disease–SARS-CoV-2 crosstalk in the olfactory mucosa
MA Shahbaz, S Kuivanen, R Lampinen… - Journal of …, 2023 - Springer
Background The neurological effects of the coronavirus disease of 2019 (COVID-19) raise
concerns about potential long-term consequences, such as an increased risk of Alzheimer's …
concerns about potential long-term consequences, such as an increased risk of Alzheimer's …
SARS-CoV-2 infection as a potential risk factor for the development of cancer
N Ogarek, P Oboza… - Frontiers in Molecular …, 2023 - frontiersin.org
The COVID-19 pandemic has a significant impact on public health and the estimated
number of excess deaths may be more than three times higher than documented in official …
number of excess deaths may be more than three times higher than documented in official …
Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine …
J Li, FM Huang, QL Ma, W Guo, KY Feng… - Frontiers in …, 2023 - frontiersin.org
The widely used ChAdOx1 nCoV-19 (ChAd) vector and BNT162b2 (BNT) mRNA vaccines
have been shown to induce robust immune responses. Recent studies demonstrated that …
have been shown to induce robust immune responses. Recent studies demonstrated that …
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
RGH Lindeboom, KB Worlock, LM Dratva, M Yoshida… - Nature, 2024 - nature.com
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the
dynamics of early cellular responses to this disease remains limited 1. Here in our SARS …
dynamics of early cellular responses to this disease remains limited 1. Here in our SARS …
Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19
L Verdiguel-Fernández, R Arredondo-Hernández… - BMC infectious …, 2023 - Springer
Background Severe COVID-19 is a disease characterized by profound dysregulation of the
innate immune system. There is a need to identify highly reliable prognostic biomarkers that …
innate immune system. There is a need to identify highly reliable prognostic biomarkers that …
[HTML][HTML] SARS-CoV-2 infection: a possible risk factor for incidence and recurrence of cancers
COVID-19 and malignancy can affect the susceptibility of one another. Clinically recovered
COVID-19 individuals display immune abnormalities that persist several months after …
COVID-19 individuals display immune abnormalities that persist several months after …
A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2
Most transcriptomic studies of SARS-CoV-2 infection have focused on differentially
expressed genes, which do not necessarily reveal the genes mediating the transcriptomic …
expressed genes, which do not necessarily reveal the genes mediating the transcriptomic …
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility
B Israelow, A Iwasaki - 2024 - nature.com
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …